Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor

Lipids in Health and Disease

Nilofer Qureshi¹  David C Morrison³  Sandra Jabre²  Christopher J Papasian³  Julia C Reis¹  Xiu Qin Guan³  Asaf A Qureshi³ 

[1] Division of Pharmacology and Toxicology, School of Pharmacy, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO, 64108, USA;Department of Microbiology and Immunology, University of Maryland, 685 W. Redwood Street, Baltimore, MD, 21201, USA;Department of Basic Medical Sciences, School of Medicine, University of Missouri, 2411 Holmes Street, Kansas City, MO, 64108, USA

关键词: Proteasome inhibitors;    Resveratrol;    Cytokines;    NF-κB;    TNF-α;    Nitric oxide (NO);   

Others  :  1160274
DOI  :  10.1186/1476-511X-11-76

 received in 2012-02-10, accepted in 2012-06-14,  发布年份 2012

【 摘 要 】

Background

Altered immune function during ageing results in increased production of nitric oxide (NO) and other inflammatory mediators. Recently, we have reported that NO production was inhibited by naturally-occurring proteasome inhibitors (quercetin, δ-tocotrienol, and riboflavin) in lipopolysaccharide (LPS)-stimulated RAW264.7 cells, and thioglycolate-elicited peritoneal macrophages from C57BL/6 mice. In a continuous effort to find more potent, non-toxic, commercially available, naturally-occurring proteasome inhibitors that suppress inflammation, the present study was carried out to describe the inhibition of NF-κB activation and NO, TNF-α, IL-6, IL-1β, and iNOS expression by trans-resveratrol, trans-pterostilbene, morin hydrate, and nicotinic acid in LPS-induced RAW 264.7 cells and thioglycolate-elicited peritoneal macrophages from C57BL/6 and BALB/c mice.

Results

The present results indicate that resveratrol, pterostilbene, and morin hydrate caused significant inhibition (>70% to 90%; P < 0.02) in the activities of chymotrypsin-like, trypsin-like, and post-acidic (post-glutamase) proteasome sites in RAW 264.7 cells at a dose of only 20 μM. These compounds also inhibited the production of NO by RAW-264.7 cells stimulated with LPS alone (>40%; P < 0.05), or LPS + interferon-γ (IFN-γ; >60%; P < 0.02). Furthermore, resveratrol, pterostilbene, morin hydrate, and quercetin suppressed secretion of TNF-α (>40%; P < 0.05) in LPS-stimulated RAW 264.7 cells, and suppressed NF-κB activation (22% to 45%; P < 0.05) in LPS-stimulated HEK293T cells. These compounds also significantly suppressed LPS-induced expression of TNF-α, IL-1β, IL-6, and iNOS genes in RAW 264.7 cells, and also in thioglycolate-elicited peritoneal macrophages from C57BL/6 and BALB/c mice.

Conclusions

The present results clearly demonstrate that resveratrol and pterostilbene are particularly potent proteasome inhibitors that suppress expression of genes, and production of inflammatory products in LPS-stimulated RAW 264.7 cells, and macrophages from C57BL/6 and BALB/c mice. Resveratrol and pterostilbene which are present in grapes, blueberries, and red wine, have been implicated as contributing factors to the lower incidence of cardiovascular disease in the French population, despite their relatively high dietary fat intake. Consequently, it appears likely that the beneficial nutritional effects of resveratrol and pterostilbene are due at least in part, to their ability to inhibit NF-κB activation by the proteasome, thereby suppressing activation of pro-inflammatory cytokines and iNOS genes, resulting in decreased secretion of TNF-α, IL-1β, IL-6, and NO levels, in response to inflammatory stimuli. This is the first report demonstrating that resveratrol and pterostilbene act as proteasome inhibitors, thus providing a mechanism for their anti-inflammatory effects.

【 授权许可】

   
2012 Qureshi et al.; licensee BioMed Central Ltd

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

【 参考文献 】

• [1]Mehta JL, Saldeen TGP, Rand K: Interactive role of infection, inflammation andtraditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol 1998, 31:1217-1225.
• [2]Libby P, Ridker PM: Novel inflammatory markers of coronary risk. Theory versus practice. Circulation 1999, 100:1148-1150.
• [3]Sen CK, Khanna S, Roy S: Tocotrienols in health and diseases: The other half of the natural vitamin E family. Molecular aspect of Medicine. 2007, 28:692-728.
• [4]Chen LC, Pace JL, Russell SW, Morrison DC: Altered regulation of inducible nitric oxide synthase expression in macrophages from senescent mice. Infect Immun 1996, 64(10):4288-4298.
• [5]Qureshi AA, Tan X, Reis JC, Badr MZ, Papasian CJ, Morrison DC, Qureshi N: Suppression of nitric oxide production and pro-inflammatory cytokines by novel proteasomes inhibitors in various experimental models. Lipids in Health and Disease 2011, 10:177. BioMed Central Full Text
• [6]Qureshi AA, Reis JC, Qureshi N, Papasian CJ, Morrison DC, Schaefer DM: δ-Tocotrienol and quercetin reduce serum levels of nitric oxide and lipid parameters in female chickens. Lipids in Health and Disease 2011, 10:39. BioMed Central Full Text
• [7]Qureshi AA, Reis JC, Papasian CJ, Morrison DC, Qureshi N: Tocotrienols inhibit lipopolysacharide-induecd pro-inflammatory cytokines in macrophages of female mice. Lipids in Health and Disease 2010, 9:143. BioMed Central Full Text
• [8]Law M, Wald N: Why heart disease mortality is low in France. British Medical Journal 1999, 318:1471-1480.
• [9]Ferrieres J: The French Paradox; Lessons for other countries. Heart 2004, 90(1):107-111.
• [10]Bradamante S, Barenghi L, Piccinini F, Bertelli AAE, de Jonge R, Beemster P, de Jong JW: Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism. Eur J Phamacology 2003, 465:115-123.
• [11]Remsberg CM, Yanez JA, Ohgami Y, Vega-Villa KR, Rimando AM, Davies NM: Phamacometric of pterostilbene: Pre-clinical pharmacokinetics and metabolism, anticancer, anti-inflammatory, antioxidant and analgesic activity. Phytother Res 2008, 22:169-179.
• [12]Yugarani T, Tan BKH, Reh M, Das NP: Effects of polyphenolic natural products on the lipid profiles of rats fed high fat diets. Lipids 1992, 27:181-186.
• [13]Middleton E, Kandaswami C, Theoharides TC: The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000, 52(4):673-751.
• [14]Federal Food, Drug and Cosmetic Act: Tocotrienols (TRF) is “Generally Recognized as Safe (GRAS)”, Title 21 Code of Federal Regulations (21 CFR). 2010. May 18, 2010. U.S. Food and Drug Administration. Silver Spring, 10903 New Hamshire Avenue; AA. MD. 20993
• [15]Qureshi N, Takayama K, Mascagni P, Honovich J, Wong R, Cotter RJ: Complete structural determination of lipopolysaccharide obtained from deep rough mutant of Escherichia coli. Purification by high performance liquid chromatography and direct analysis by plasma desorption mass spectrometry. J Biol Chem 1988, 263:11971-11976.
• [16]Shen J, Gao JJ, Zhang G, Tan X, Morrison DC, Papasian CJ, Vogel SN, Qureshi N: Proteasome inhibitor, lactacystin blocks CpG DNA- and peptidoglycan induced inflammatory genes, cytokines and mitogen-activated protein kinases in macrophages. Shock 2006, 25:594-599.
• [17]Lei MG, Tan X, Qureshi N, Morrison DC: Regulation of cellular caveolin-1 protein expression in murine macrophages by microbial products. Infect Immun 2005, 73:8136-8143.
• [18]Stuehr DJ, Nathan CF: Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 1989, 169:1543-1555.
• [19]Rallabhandi P, Bell J, Boukhvalova MS, Medvedev A, Lorenz E, Arditi M, Hemming VG, Balnco JCG, Segal DA, Vogel SN: Analysis of TLR4 polymorphic variants: New insight into TLR4/MD-2/CD14 stoichiometry, structure, and signaling. J Immunol 2006, 177:322-332.
• [20]Denizot F, Lang R: Rapid colorimetric assay for cell growth and survival. Modification to the tetrazolium dye procedure giving improved sensibility and reliability. J Immunol Methods 1986, 89:271-277.
• [21]Chomczynski P, Saachi N: Single step method of RNA isolation by acid guaninium-phenol-chloroform extraction. Ana Biochem 1987, 162:156-159.
• [22]Reis J, Guan XQ, Kisselev AF, Papasian CJ, Qureshi AA, Morrison DC, Van Way CW, Vogel SN, Qureshi N: LPS-induced formation of immune-proteasome: TNF-α and nitric oxide production are regulated by altered composition of proteasome-active sites. Cell Biochemistry and Biophysics 2011, 60:77-88.
• [23]Reis J, Hassan F, Guan XQ, Shen J, Monaco JJ, Papasian CJ, Qureshi AA, Van Way CW, Vogel SN, Morrison DC, Qureshi N: The immunoproteasome regulate LPS-inducedTRIF/TRAM signaling pathway in murine macrophages. Cell Biochemistry and Biophysics 2011, 60:119-126.
• [24]Nam N: Naturally-occurring NF-κB inhibitors. Mini-Reviews in Medicinal Chemistry 2006, 6:945-951.
• [25]Qureshi N, Vogel SN, Way CV, Papasian CJ, Qureshi AA, Morison DC: The proteasome: A central regulator of inflammation and macrophage function. Immunological Research 2005, 31(3):243-260.
• [26]Huang S, Zhao L, Kim K, Lee DS, Hwang DH: Inhibition of Nod2 signaling and target geneepression by curcumin. Mol Phamacol 2008, 74:274-281.
• [27]Qureshi AA, Tan X, Reis JC, Badr MZ, Papasian CJ, Morrison DC, Qureshi N: Inhibition of nitric oxide in LPS-stimulated macrophages of young and senescent mice by δ- tocotrienol and quercetin. Lipids in Health and Disease 2011, 10:239. BioMed Central Full Text
• [28]Barnes PJ, Karin M: Nuclear factor kappa B: a pivotal transcription factor in chronic inflammatory diseases. New Eng J Med 1997, 336:1066-1071.
• [29]Youn HS, Lee JY, Fitzgerald KA, Young HA, Akira S, Hwang DH: Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: Molecular targets are TBK1 and RIP1 in TRIF complex. J Immunol 2005, 175:3339-3346.